Evaluation of the Paraoxonase-1 Level in Patients with Acute Pancreatitis

Overview

Journal Curr Health Sci J

Specialty General Medicine

Date 2023 Oct 2

PMID 37780188

Authors

Rukiye Yildiz

Ahmet Uyanikoglu

Cigdem Cindoglu

Mehmet Ali Eren

Ismail Koyuncu

Affiliations

Soon will be listed here.

Abstract

Background: This study, aimed to evaluate the role of paraoxonase-1 (PON-1), in the pathogenesis of acute pancreatitis (AP). PON-1 plays a significant role in antioxidant, anti-inflammatory and antiatherogenic responses and may help predict the severity of AP.

Methods: A total of 50 patients with AP and 45 healthy volunteers were included in the study. AP was diagnosed when serum amylase and/or lipase values increased threefold and/or more than the upper limit of normal, together with a complaint of abdominal pain. Modified Atlanta and Ranson scoring were used for AP severity.

Results: AP causes were biliary for 35 (70%) patients and idiopathic for 8 (16%) patients, AP developed in 6 (12%) patients after endoscopic retrograde pancreatography, and AP in 1 (2%) patient was a consequence hypertriglyceridemia. No difference in PON-1 level was found between the groups (PON-1=197.06±164.6 and 192.1±111.78, respectively, p=0.86). On the other hand, patients were stratified according to the modified Atlanta (177.5±166.8 for mild to moderate vs. 268.5±64.2 for severe, p<0.018) or Ranson (163.2±133.06 for mild vs. 208.8±158.0 for severe, p<0.016). PON-1 level was significantly higher in patients with severe AP compared to patients with mild and/or moderate disease.

Conclusion: Although PON-1 level did not differ in patients with and without AP, PON-1 level increased significantly in parallel with the severity of AP. Thus, PON-1 can be a potential marker for the severity of the disease and can predict prognosis.

References

Perla-Kajan J, Jakubowski H . Paraoxonase 1 and homocysteine metabolism. Amino Acids. 2012; 43(4):1405-17. DOI: 10.1007/s00726-012-1321-z. View

Banks P, Bollen T, Dervenis C, Gooszen H, Johnson C, Sarr M . Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2012; 62(1):102-11. DOI: 10.1136/gutjnl-2012-302779. View

Uyanikoglu A, Sabuncu T, Yildiz R, Cindioglu C, Kirmit A, Erel O . Impaired thiol/disulfide homeostasis in patients with mild acute pancreatitis. Turk J Gastroenterol. 2019; 30(10):899-902. PMC: 6812960. DOI: 10.5152/tjg.2019.18775. View

Roberts S, Morrison-Rees S, John A, Williams J, Brown T, Samuel D . The incidence and aetiology of acute pancreatitis across Europe. Pancreatology. 2017; 17(2):155-165. DOI: 10.1016/j.pan.2017.01.005. View

Zhou M, Chen C, Chen B, Zhang Q, Andersson R . Acute lung injury and ARDS in acute pancreatitis: mechanisms and potential intervention. World J Gastroenterol. 2010; 16(17):2094-9. PMC: 2864834. DOI: 10.3748/wjg.v16.i17.2094. View

Dumnicka P, Maduzia D, Ceranowicz P, Olszanecki R, Drozdz R, Kusnierz-Cabala B . The Interplay between Inflammation, Coagulation and Endothelial Injury in the Early Phase of Acute Pancreatitis: Clinical Implications. Int J Mol Sci. 2017; 18(2). PMC: 5343889. DOI: 10.3390/ijms18020354. View

Drehmer E, Platero J, Carrera-Julia S, Moreno M, Tvarijonaviciute A, Navarro M . The Relation between Eating Habits and Abdominal Fat, Anthropometry, PON1 and IL-6 Levels in Patients with Multiple Sclerosis. Nutrients. 2020; 12(3). PMC: 7146613. DOI: 10.3390/nu12030744. View

Freeman M, DiSario J, Nelson D, Fennerty M, Lee J, Bjorkman D . Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001; 54(4):425-34. DOI: 10.1067/mge.2001.117550. View

Kaplan M, Ates I, Oztas E, Yuksel M, Akpinar M, Coskun O . A New Marker to Determine Prognosis of Acute Pancreatitis: PLR and NLR Combination. J Med Biochem. 2018; 37(1):21-30. PMC: 6294107. DOI: 10.1515/jomb-2017-0039. View

10.

Xiao A, Tan M, Wu L, Asrani V, Windsor J, Yadav D . Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol. 2017; 1(1):45-55. DOI: 10.1016/S2468-1253(16)30004-8. View

11.

Camps J, Marsillach J, Joven J . The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci. 2009; 46(2):83-106. DOI: 10.1080/10408360802610878. View

12.

Jiang X, Zheng Y, Bao S, Zhang H, Chen R, Yao Q . Drug discovery and formulation development for acute pancreatitis. Drug Deliv. 2020; 27(1):1562-1580. PMC: 7598990. DOI: 10.1080/10717544.2020.1840665. View

13.

Marek G, Sciskalska M, Grzebieniak Z, Milnerowicz H . Decreases in Paraoxonase-1 Activities Promote a Pro-inflammatory Effect of Lipids Peroxidation Products in Non-smoking and Smoking Patients with Acute Pancreatitis. Int J Med Sci. 2018; 15(14):1619-1630. PMC: 6299411. DOI: 10.7150/ijms.27647. View

14.

Peery A, Crockett S, Murphy C, Lund J, Dellon E, Williams J . Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterology. 2018; 156(1):254-272.e11. PMC: 6689327. DOI: 10.1053/j.gastro.2018.08.063. View

15.

Verlaan M, Harbers E, Pap A, Jansen J, Peters W, Drenth J . Paraoxonase 1-192Q allele is a risk factor for idiopathic chronic pancreatitis. Mol Diagn. 2005; 9(1):9-15. DOI: 10.2165/00066982-200509010-00002. View

16.

Zhou M, Liu X, Liu Q, Chen M, Bai H, Guan L . Lactonase Activity, Status, and Genetic Variations of Paraoxonase 1 in Women with Gestational Diabetes Mellitus. J Diabetes Res. 2020; 2020:3483427. PMC: 7023839. DOI: 10.1155/2020/3483427. View

17.

Yang Z, Meng X, Xu P . Central role of neutrophil in the pathogenesis of severe acute pancreatitis. J Cell Mol Med. 2015; 19(11):2513-20. PMC: 4627557. DOI: 10.1111/jcmm.12639. View

18.

Draganov D, Teiber J, Speelman A, Osawa Y, Sunahara R, La Du B . Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res. 2005; 46(6):1239-47. DOI: 10.1194/jlr.M400511-JLR200. View

19.

Petrov M, Yadav D . Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol. 2018; 16(3):175-184. PMC: 6597260. DOI: 10.1038/s41575-018-0087-5. View

20.

Gugliucci A, Caccavello R, Nassar H, Abu Ahmad W, Sinnreich R, Kark J . Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes. Clin Chim Acta. 2015; 445:41-7. DOI: 10.1016/j.cca.2015.03.012. View